The company, Biotricity — which focuses on lowering healthcare costs by using technology to manage chronic diseases — was hit with a 25 percent tariff on Chinese-imported parts that went into effect Sept. 1.
Many of the small mechanical parts Biotricity uses in its devices are only made in China, the company told Fox Business.
One of Biotricity’s suppliers told Fox Business it plans to raise the price of its products because it can’t absorb the costs of the tariffs.
The Medical Imaging and Technology Alliance estimated the new tariffs will cost the U.S. medical technology industry about $138 million.
More articles on supply chain:
Judge approves reopening of Sterigenics, whose February closure caused device shortages
New ‘supercooling’ storage technique may increase number of liver transplants
Sales stall for medical device designed as opioid alternative
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.